These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1832718)

  • 21. A single base insertion in the putative transmembrane domain of the tyrosinase gene as a cause for tyrosinase-negative oculocutaneous albinism.
    Chintamaneni CD; Halaban R; Kobayashi Y; Witkop CJ; Kwon BS
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5272-6. PubMed ID: 1711223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of the tyrosinase gene in oculocutaneous albinism.
    Shibahara S
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene.
    Tomita Y; Takeda A; Okinaga S; Tagami H; Shibahara S
    Biochem Biophys Res Commun; 1989 Nov; 164(3):990-6. PubMed ID: 2511845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New nonsense mutation (p.E250X) in the tyrosinase gene of a patient with oculocutaneous albinism type 1A].
    Aquaron R; Hesse S; Badens C; Bonerandi JJ
    Ann Dermatol Venereol; 2009 Jan; 136(1):57-9. PubMed ID: 19171234
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
    Oetting WS; King RA
    Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
    Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
    N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analyses of a tyrosinase-negative albino family.
    Park KC; Chintamaneni CD; Halaban R; Witkop CJ; Kwon BS
    Am J Hum Genet; 1993 Feb; 52(2):406-13. PubMed ID: 8430701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.
    Oetting WS; Mentink MM; Summers CG; Lewis RA; White JG; King RA
    Am J Hum Genet; 1991 Jul; 49(1):199-206. PubMed ID: 1905879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).
    Lee ST; Nicholls RD; Schnur RE; Guida LC; Lu-Kuo J; Spinner NB; Zackai EH; Spritz RA
    Hum Mol Genet; 1994 Nov; 3(11):2047-51. PubMed ID: 7874125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico.
    Oetting WS; Witkop CJ; Brown SA; Colomer R; Fryer JP; Bloom KE; King RA
    Am J Hum Genet; 1993 Jan; 52(1):17-23. PubMed ID: 8434585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1).
    Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV
    Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202
    [No Abstract]   [Full Text] [Related]  

  • 35. A trinucleotide deletion together with a base duplication event at codon 439 in the human tyrosinase gene identifies a mutational hotspot.
    Breimer LH; Winder AF; Panayiotidis P; Jay M; Moore A; Jay B
    Clin Chim Acta; 1995 Dec; 243(1):35-42. PubMed ID: 8747512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
    Shimizu H
    Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-strand conformation polymorphism analysis of point mutation in a tyrosinase-negative oculocutaneous albinism.
    Park KC; Kim KH; Lee YS; Kwon BS
    J Inherit Metab Dis; 1994; 17(1):123-6. PubMed ID: 8051921
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular basis of albinism in the rhesus monkey.
    Ding B; Ryder OA; Wang X; Bai SC; Zhou SQ; Zhang Y
    Mutat Res; 2000 Apr; 449(1-2):1-6. PubMed ID: 10751629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R
    Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.
    Oetting WS; Pietsch J; Brott MJ; Savage S; Fryer JP; Summers CG; King RA
    Am J Med Genet A; 2009 Mar; 149A(3):466-9. PubMed ID: 19208379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.